Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001789507-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-07 | 2026-01-05 | INDV | Wheadon David E. | Dir | P - Purchase | $35.39 | +1,771 | 14.4K | +14% | +$62.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-05 | P | A | 1,771 | $35.39 | 14,395 | D | — | — |